In systemic lupus erythematosus (SLE), binding of αM integrins with CD22 downregulated B-cell receptor signaling to maintain autoreactive B-cell tolerance and further inhibited SLE progression [97]. The gene discussed is CD22; the disease is systemic lupus erythematosus.